News & Media

Press Releases

Amolyt Pharma Exercises Option to License Optimized Acromegaly Drug Candidate from PeptiDream as it Continues to Build its Rare Endocrine Pipeline

Download a PDF copy of this press release: EN FR Company to develop AZP-3813 as a potential treatment for acromegaly following successful research collaboration between …

Download a PDF: EN or FR

Amolyt Pharma Announces Appointment of Two Directors

Download a PDF copy of this press release: EN FR Elisabeth Svanberg, M.D., Ph.D. brings extensive experience in the development of therapeutics for under-served endocrine, …

Download a PDF: EN or FR

Amolyt Pharma Announces Hiring of Louis J. Arcudi III as Chief Financial Officer

Download a PDF copy of this press release: EN FR Appointment of US-based CFO adds more than 20 years of biotechnology financial, strategic, and operational …

Download a PDF: EN or FR

Upcoming events

Date: September 29 – October 3, 2021 (Virtual)

Learn more about the conference »

Date: October 2021

Date: October 1-4, 2021 (Toronto)

Learn more about the conference »

Date: October 13-16, 2021 (Le Havre)

Learn more about the conference »

Date: October 19-22, 2021 (Denver, CO)

Learn more about the conference »

Date: November 2-7, 2021 (San Diego, CA)

Learn more about the conference »

Date: November 1, 2021

Social Updates

TWITTER

Scroll to Top